Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 13, 2022 16:30 ET | Source: Conformis, Inc.

Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration

BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced...
August 29, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference

BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
August 08, 2022 16:45 ET | Source: Conformis, Inc.

Conformis Reports Second Quarter 2022 Financial Results

BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
August 01, 2022 16:30 ET | Source: Conformis, Inc.

Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants

BILLERICA, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc., (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced it...
July 28, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
July 05, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022

BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...
May 24, 2022 08:00 ET | Source: Conformis, Inc.

Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity

BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced...
May 10, 2022 08:00 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference

BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that...
May 04, 2022 07:00 ET | Source: Conformis, Inc.

Conformis Reports First Quarter 2022 Financial Results

BILLERICA, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
April 11, 2022 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022

BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the...